The Scientist

» reagents, culture and cell & molecular biology

Most Recent

image: Identifying Diet-Treatable Diseases

Identifying Diet-Treatable Diseases

By | April 10, 2012

Scientists test which mutations underlie metabolic diseases that may benefit from changes in diet.

6 Comments

image: News from Cancer Meeting

News from Cancer Meeting

By | April 4, 2012

A roundup of recent research announced this week at the annual conference of the American Association for Cancer Research (AACR).

4 Comments

image: Lab Studies Lie about the Clock

Lab Studies Lie about the Clock

By | April 4, 2012

Fly circadian behavior is dramatically different in natural environments than in the lab.

10 Comments

image: A Malignant Alliance

A Malignant Alliance

By | April 1, 2012

Two proteins interact to save adhesion molecules from degradation, potentially contributing to a more aggressive cancer.

2 Comments

Contributors

April 1, 2012

Meet some of the people featured in the April 2012 issue of The Scientist.

0 Comments

image: Are Cancer Stem Cells Ready for Prime Time?

Are Cancer Stem Cells Ready for Prime Time?

By | April 1, 2012

A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.

48 Comments

image: Eyes on Cancer

Eyes on Cancer

By | April 1, 2012

Techniques for watching tumors do their thing

4 Comments

image: Live and In Color

Live and In Color

By | April 1, 2012

How to track RNA in living cells

2 Comments

image: The World in a Cabinet, 1600s

The World in a Cabinet, 1600s

By | April 1, 2012

A 17th century Danish doctor arranges a museum of natural history oddities in his own home.

2 Comments

image: Truth and Beauty

Truth and Beauty

By | April 1, 2012

With strong foundations in both art and science, Ahna Skop has been able to capture the marvel of—and mechanisms behind—cytokinesis.

4 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech